Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin Abuse Potential with Oxycodone in Recreational Opioid Users
NCT07813026Phase 4Recruiting
- Sponsor
- Viatris
- Start
- Aug 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of gabapentin (6 arms), sponsored by Viatris. Primary endpoint: Bipolar Visual Analog Scale (VAS) for 'Drug Liking' Maximum Effect (Emax) up to 24 hours. Started Aug 2026; status: recruiting.
02
Drugs
gabapentin
Beyond the preview
Go deeper on NCT07813026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07813026.